scholarly article | Q13442814 |
P2093 | author name string | Yi Li | |
Dongmei Wang | |||
Fangfang Guo | |||
Aihua Yin | |||
Yiming Qi | |||
Yaping Hou | |||
Haishan Peng | |||
Jiexia Yang | |||
Yixia Wang | |||
Xiaohui Luo | |||
P2860 | cites work | Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma | Q33360224 |
Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing | Q33665399 | ||
Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing | Q34256640 | ||
Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma | Q34336915 | ||
Rapid clearance of fetal DNA from maternal plasma | Q34388637 | ||
Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study | Q34482155 | ||
High-throughput massively parallel sequencing for fetal aneuploidy detection from maternal plasma | Q34618332 | ||
A multifactorial relationship exists between total circulating cell-free DNA levels and maternal BMI | Q36205202 | ||
Noninvasive detection of fetal subchromosomal abnormalities by semiconductor sequencing of maternal plasma DNA | Q36332125 | ||
Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women | Q36354286 | ||
Non-invasive prenatal testing for Down syndrome | Q38161185 | ||
Cell-Free DNA Screening: Complexities and Challenges of Clinical Implementation. | Q38928166 | ||
Noninvasive prenatal testing for aneuploidy using cell-free DNA - New implications for maternal health. | Q39004076 | ||
Size distributions of maternal and fetal DNA in maternal plasma. | Q47432593 | ||
Cell-Free DNA Screening for Aneuploidy and Microdeletion Syndromes | Q50083914 | ||
Cell-Free DNA Analysis of Targeted Genomic Regions in Maternal Plasma for Non-Invasive Prenatal Testing of Trisomy 21, Trisomy 18, Trisomy 13, and Fetal Sex. | Q50658711 | ||
Determination of fetal DNA fraction from the plasma of pregnant women using sequence read counts. | Q51025463 | ||
Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X. | Q51163080 | ||
Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. | Q51349861 | ||
Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. | Q51767524 | ||
Early detection of cell-free fetal DNA in maternal plasma. | Q53576548 | ||
The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. | Q54708648 | ||
Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics | Q61847812 | ||
Fetal Fraction in Maternal Plasma Cell-Free DNA at 11–13 Weeks’ Gestation: Effect of Maternal and Fetal Factors | Q61847823 | ||
The Quest for Accurate Measurement of Fetal DNA in Maternal Plasma | Q85023769 | ||
Factors affecting levels of circulating cell-free fetal DNA in maternal plasma and their implications for noninvasive prenatal testing | Q85218234 | ||
Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy | Q85495453 | ||
Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeks | Q85632797 | ||
Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result | Q87035902 | ||
Non-Invasive Prenatal Testing (NIPT) in pregnancies with trisomy 21, 18 and 13 performed in a public setting - factors of importance for correct interpretation of results | Q88873306 | ||
P433 | issue | 1 | |
P921 | main subject | statistics | Q12483 |
P304 | page(s) | 62 | |
P577 | publication date | 2019-12-04 | |
P1433 | published in | Human genomics | Q26842690 |
P1476 | title | Factors affecting cell-free DNA fetal fraction: statistical analysis of 13,661 maternal plasmas for non-invasive prenatal screening | |
P478 | volume | 13 |
Search more.